{"transactions":[{"id":4632423,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2026-10-02T18:58:27.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":20558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":20558,"derivative":{"exercise_price":12.24,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":20558},"source":{"system":"sec-edgar","filing":"0000711377-26-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137726000022/primary_doc.xml","form_type":"4"}},{"id":4632422,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-10-02T18:58:27.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":9804,"price":12.24,"value":120000.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":42306,"source":{"system":"sec-edgar","filing":"0000711377-26-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137726000022/primary_doc.xml","form_type":"4"}},{"id":729062,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-06-23T21:24:38.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on June 18, 2026. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2027."}],"balance_after":14950,"derivative":{"exercise_price":34.16,"expiration_date":"2036-06-18","underlying":"Common stock","underlying_shares":14950},"source":{"system":"sec-edgar","filing":"0001439222-26-000105","document":"wk-form4_1782249875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000105/wk-form4_1782249875.xml","form_type":"4"}},{"id":729061,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-23T21:24:38.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":2927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2927,"derivative":{"underlying":"Common stock","underlying_shares":2927},"source":{"system":"sec-edgar","filing":"0001439222-26-000105","document":"wk-form4_1782249875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000105/wk-form4_1782249875.xml","form_type":"4"}},{"id":729060,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-23T21:24:38.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2816},"source":{"system":"sec-edgar","filing":"0001439222-26-000105","document":"wk-form4_1782249875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000105/wk-form4_1782249875.xml","form_type":"4"}},{"id":729059,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-06-23T21:24:38.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10865,"source":{"system":"sec-edgar","filing":"0001439222-26-000105","document":"wk-form4_1782249875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000105/wk-form4_1782249875.xml","form_type":"4"}},{"id":736076,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-16T20:06:47.000Z","date":"2026-06-13","kind":"exercise","planned":false,"acquired":false,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1976},"source":{"system":"sec-edgar","filing":"0001439222-26-000075","document":"wk-form4_1781640401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000075/wk-form4_1781640401.xml","form_type":"4"}},{"id":736075,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-06-16T20:06:47.000Z","date":"2026-06-13","kind":"exercise","planned":false,"acquired":true,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8049,"source":{"system":"sec-edgar","filing":"0001439222-26-000075","document":"wk-form4_1781640401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000075/wk-form4_1781640401.xml","form_type":"4"}},{"id":1012295,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-29T14:08:54.000Z","date":"2025-10-27","kind":"exercise","planned":false,"acquired":false,"shares":1777,"price":6.19,"value":10999.63,"ownership":{"direct":true},"balance_after":1777,"derivative":{"exercise_price":6.19,"exercise_date":"2025-10-27","expiration_date":"2025-10-27","underlying":"Common Stock","underlying_shares":1777},"source":{"system":"sec-edgar","filing":"0000711377-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000071/primary_doc.xml","form_type":"4"}},{"id":1012294,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-29T14:08:54.000Z","date":"2025-10-27","kind":"exercise","planned":false,"acquired":true,"shares":1777,"price":6.19,"value":10999.63,"ownership":{"direct":true},"balance_after":32502,"source":{"system":"sec-edgar","filing":"0000711377-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000071/primary_doc.xml","form_type":"4"}},{"id":1012952,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-28T13:52:18.000Z","date":"2025-10-27","kind":"exercise","planned":false,"acquired":false,"shares":2025,"price":6.19,"value":12534.75,"ownership":{"direct":true},"balance_after":4050,"derivative":{"exercise_price":6.19,"exercise_date":"2025-10-27","expiration_date":"2025-10-27","underlying":"Common Stock","underlying_shares":2025},"source":{"system":"sec-edgar","filing":"0000711377-25-000060","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000060/primary_doc.xml","form_type":"4"}},{"id":1012951,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-28T13:52:18.000Z","date":"2025-10-27","kind":"exercise","planned":false,"acquired":true,"shares":2025,"price":6.19,"value":12534.75,"ownership":{"direct":true},"balance_after":30725,"source":{"system":"sec-edgar","filing":"0000711377-25-000060","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000060/primary_doc.xml","form_type":"4"}},{"id":1013492,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-10-27T19:45:31.000Z","date":"2025-10-23","kind":"grant","planned":false,"acquired":true,"shares":50814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":50814,"derivative":{"exercise_price":6.07,"expiration_date":"2035-10-23","underlying":"Common Stock","underlying_shares":50814},"source":{"system":"sec-edgar","filing":"0000711377-25-000051","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000051/primary_doc.xml","form_type":"4"}},{"id":1013491,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-27T19:45:31.000Z","date":"2025-10-23","kind":"grant","planned":false,"acquired":true,"shares":19769,"price":6.07,"value":119997.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":48469,"source":{"system":"sec-edgar","filing":"0000711377-25-000051","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000051/primary_doc.xml","form_type":"4"}},{"id":1021110,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-09T20:48:12.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":2071,"price":5.63,"value":11659.73,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.63,"exercise_date":"2025-10-07","expiration_date":"2025-10-07","underlying":"Common Stock","underlying_shares":2071},"source":{"system":"sec-edgar","filing":"0000711377-25-000037","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000037/primary_doc.xml","form_type":"4"}},{"id":1021109,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-09T20:48:12.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":true,"shares":2071,"price":5.63,"value":11659.73,"ownership":{"direct":true},"balance_after":28700,"source":{"system":"sec-edgar","filing":"0000711377-25-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000037/primary_doc.xml","form_type":"4"}},{"id":1103669,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-23T20:25:37.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2120},"source":{"system":"sec-edgar","filing":"0001439222-25-000059","document":"wk-form4_1750710331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000059/wk-form4_1750710331.xml","form_type":"4"}},{"id":1103668,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-23T20:25:37.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":15768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on June 18, 2025. The shares underlying this option vest as to 100% of the underlying shares on June 18, 2026."}],"balance_after":15768,"derivative":{"exercise_price":35.5,"expiration_date":"2035-06-18","underlying":"Common stock","underlying_shares":15768},"source":{"system":"sec-edgar","filing":"0001439222-25-000059","document":"wk-form4_1750710331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000059/wk-form4_1750710331.xml","form_type":"4"}},{"id":1103667,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-23T20:25:37.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":2861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2861,"derivative":{"underlying":"Common stock","underlying_shares":2861},"source":{"system":"sec-edgar","filing":"0001439222-25-000059","document":"wk-form4_1750710331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000059/wk-form4_1750710331.xml","form_type":"4"}},{"id":1103666,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-23T20:25:37.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6073,"source":{"system":"sec-edgar","filing":"0001439222-25-000059","document":"wk-form4_1750710331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000059/wk-form4_1750710331.xml","form_type":"4"}},{"id":1107845,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-17T20:16:37.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":false,"shares":1977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":1976,"derivative":{"underlying":"Common stock","underlying_shares":1977},"source":{"system":"sec-edgar","filing":"0001439222-25-000045","document":"wk-form4_1750191390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000045/wk-form4_1750191390.xml","form_type":"4"}},{"id":1107844,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-17T20:16:37.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":true,"shares":1977,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3953,"source":{"system":"sec-edgar","filing":"0001439222-25-000045","document":"wk-form4_1750191390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000045/wk-form4_1750191390.xml","form_type":"4"}},{"id":1168030,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-22T19:37:21.000Z","date":"2025-04-22","kind":"purchase","planned":false,"acquired":true,"shares":20712,"price":4.8386,"value":100217.0832,"ownership":{"direct":true},"balance_after":26629,"source":{"system":"sec-edgar","filing":"0000711377-25-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137725000007/primary_doc.xml","form_type":"4"}},{"id":1380442,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-29T17:26:56.000Z","date":"2024-10-28","kind":"exercise","planned":false,"acquired":false,"shares":1776,"price":13.81,"value":24526.56,"ownership":{"direct":true},"balance_after":3552,"derivative":{"exercise_price":13.81,"exercise_date":"2024-10-28","expiration_date":"2024-10-28","underlying":"Common Stock","underlying_shares":1776},"source":{"system":"sec-edgar","filing":"0000711377-24-000051","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137724000051/primary_doc.xml","form_type":"4"}},{"id":1380441,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-29T17:26:56.000Z","date":"2024-10-28","kind":"exercise","planned":false,"acquired":true,"shares":1776,"price":13.81,"value":24526.56,"ownership":{"direct":true},"balance_after":5917,"source":{"system":"sec-edgar","filing":"0000711377-24-000051","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137724000051/primary_doc.xml","form_type":"4"}},{"id":1380972,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-10-28T14:28:42.000Z","date":"2024-10-24","kind":"grant","planned":false,"acquired":true,"shares":18653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":18653,"derivative":{"exercise_price":13.58,"expiration_date":"2031-10-24","underlying":"Common Stock","underlying_shares":18653},"source":{"system":"sec-edgar","filing":"0000711377-24-000039","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137724000039/primary_doc.xml","form_type":"4"}},{"id":1380971,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-28T14:28:42.000Z","date":"2024-10-24","kind":"grant","planned":false,"acquired":true,"shares":6075,"price":13.58,"value":82498.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":15840,"source":{"system":"sec-edgar","filing":"0000711377-24-000039","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137724000039/primary_doc.xml","form_type":"4"}},{"id":1388874,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-09T17:25:45.000Z","date":"2024-10-07","kind":"exercise","planned":false,"acquired":false,"shares":2070,"price":15.07,"value":31194.9,"ownership":{"direct":true},"balance_after":2071,"derivative":{"exercise_price":15.07,"exercise_date":"2024-10-07","expiration_date":"2024-10-07","underlying":"Common Stock","underlying_shares":2070},"source":{"system":"sec-edgar","filing":"0000711377-24-000028","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137724000028/primary_doc.xml","form_type":"4"}},{"id":1388873,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-09T17:25:45.000Z","date":"2024-10-07","kind":"exercise","planned":false,"acquired":true,"shares":2070,"price":15.07,"value":31194.9,"ownership":{"direct":true},"balance_after":4141,"source":{"system":"sec-edgar","filing":"0000711377-24-000028","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137724000028/primary_doc.xml","form_type":"4"}},{"id":1470595,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2024-06-24T20:10:35.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":11774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 20, 2024. The shares underlying this option vest as to 100% of the underlying shares on June 20, 2025."}],"balance_after":11774,"derivative":{"exercise_price":42.45,"expiration_date":"2034-06-20","underlying":"Common stock","underlying_shares":11774},"source":{"system":"sec-edgar","filing":"0001439222-24-000107","document":"wk-form4_1719259827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000107/wk-form4_1719259827.xml","form_type":"4"}},{"id":1470594,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-06-24T20:10:35.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2120,"derivative":{"underlying":"Common stock","underlying_shares":2120},"source":{"system":"sec-edgar","filing":"0001439222-24-000107","document":"wk-form4_1719259827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000107/wk-form4_1719259827.xml","form_type":"4"}},{"id":1477198,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-06-17T21:13:54.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":false,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":3953,"derivative":{"underlying":"Common stock","underlying_shares":1976},"source":{"system":"sec-edgar","filing":"0001439222-24-000075","document":"wk-form4_1718658827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000075/wk-form4_1718658827.xml","form_type":"4"}},{"id":1477197,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-06-17T21:13:54.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":true,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1976,"source":{"system":"sec-edgar","filing":"0001439222-24-000075","document":"wk-form4_1718658827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000075/wk-form4_1718658827.xml","form_type":"4"}},{"id":1753581,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-10-31T20:21:13.000Z","date":"2023-10-26","kind":"exercise","planned":false,"acquired":true,"shares":5329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":9470,"derivative":{"exercise_price":15.48,"expiration_date":"2026-10-26","underlying":"Common Stock","underlying_shares":5329},"source":{"system":"sec-edgar","filing":"0000711377-23-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137723000023/primary_doc.xml","form_type":"4"}},{"id":1753580,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2023-10-31T20:21:13.000Z","date":"2023-10-26","kind":"exercise","planned":false,"acquired":true,"shares":13716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":32132,"derivative":{"exercise_price":15.48,"expiration_date":"2030-10-26","underlying":"Common Stock","underlying_shares":13716},"source":{"system":"sec-edgar","filing":"0000711377-23-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137723000023/primary_doc.xml","form_type":"4"}},{"id":1854219,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2023-06-15T20:30:47.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":33177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 13, 2023. The shares underlying this option vest as to 25% of the underlying shares on June 13, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":33177,"derivative":{"exercise_price":26.56,"expiration_date":"2033-06-13","underlying":"Common stock","underlying_shares":33177},"source":{"system":"sec-edgar","filing":"0001439222-23-000087","document":"wk-form4_1686861037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000087/wk-form4_1686861037.xml","form_type":"4"}},{"id":1854218,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2023-06-15T20:30:47.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":5929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":5929,"derivative":{"underlying":"Common stock","underlying_shares":5929},"source":{"system":"sec-edgar","filing":"0001439222-23-000087","document":"wk-form4_1686861037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000087/wk-form4_1686861037.xml","form_type":"4"}},{"id":2139923,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-10-11T21:03:23.000Z","date":"2022-10-06","kind":"exercise","acquired":true,"shares":6212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":6212,"derivative":{"exercise_price":13.28,"expiration_date":"2025-10-06","underlying":"Common Stock","underlying_shares":6212},"source":{"system":"sec-edgar","filing":"0000711377-22-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137722000023/primary_doc.xml","form_type":"4"}},{"id":2139922,"issuer":{"id":4338,"kind":"organization","name":"NEOGEN CORP","symbol":"NEOG"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2022-10-11T21:03:23.000Z","date":"2022-10-06","kind":"exercise","acquired":true,"shares":18416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants"}],"balance_after":18416,"derivative":{"exercise_price":13.28,"expiration_date":"2029-10-06","underlying":"Common Stock","underlying_shares":18416},"source":{"system":"sec-edgar","filing":"0000711377-22-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711377/000071137722000023/primary_doc.xml","form_type":"4"}},{"id":3272117,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:27:32.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":2253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":8348,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":2253},"source":{"system":"sec-edgar","filing":"0001127602-20-005773","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005773/form4.xml","form_type":"4"}},{"id":3272116,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:27:32.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":1919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":10601,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1919},"source":{"system":"sec-edgar","filing":"0001127602-20-005773","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005773/form4.xml","form_type":"4"}},{"id":3272115,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:27:32.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":10550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":10550,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":10550},"source":{"system":"sec-edgar","filing":"0001127602-20-005773","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005773/form4.xml","form_type":"4"}},{"id":3272114,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-14T23:27:32.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":614,"price":331.76,"value":203700.64,"ownership":{"direct":true},"balance_after":3118,"source":{"system":"sec-edgar","filing":"0001127602-20-005773","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005773/form4.xml","form_type":"4"}},{"id":3272113,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-14T23:27:32.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":1919,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3732,"source":{"system":"sec-edgar","filing":"0001127602-20-005773","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005773/form4.xml","form_type":"4"}},{"id":3320012,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-01-06T21:14:02.000Z","date":"2020-01-02","kind":"other","acquired":false,"shares":1690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":2996,"derivative":{"exercise_price":0,"expiration_date":"2021-01-02","underlying":"Common Stock","underlying_shares":1690},"source":{"system":"sec-edgar","filing":"0001127602-20-001123","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220001123/form4.xml","form_type":"4"}},{"id":3320011,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-01-06T21:14:02.000Z","date":"2020-01-02","kind":"exercise","acquired":false,"shares":1302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":4686,"derivative":{"exercise_price":0,"expiration_date":"2021-01-02","underlying":"Common Stock","underlying_shares":1302},"source":{"system":"sec-edgar","filing":"0001127602-20-001123","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220001123/form4.xml","form_type":"4"}},{"id":3320010,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-06T21:14:02.000Z","date":"2020-01-02","kind":"tax_withholding","acquired":false,"shares":406,"price":294.2,"value":119445.2,"ownership":{"direct":true},"balance_after":1813,"source":{"system":"sec-edgar","filing":"0001127602-20-001123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220001123/form4.xml","form_type":"4"}},{"id":3320009,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-06T21:14:02.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":1302,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2219,"source":{"system":"sec-edgar","filing":"0001127602-20-001123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220001123/form4.xml","form_type":"4"}},{"id":3658353,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T23:05:55.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":12520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":12520,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":12520},"source":{"system":"sec-edgar","filing":"0001127602-19-006075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219006075/form4.xml","form_type":"4"}},{"id":3706021,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-01-04T21:17:58.000Z","date":"2019-01-02","kind":"other","acquired":false,"shares":1661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":5988,"derivative":{"exercise_price":0,"expiration_date":"2021-01-02","underlying":"Common Stock","underlying_shares":1661},"source":{"system":"sec-edgar","filing":"0001127602-19-001282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219001282/form4.xml","form_type":"4"}},{"id":3706020,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-01-04T21:17:58.000Z","date":"2019-01-02","kind":"exercise","acquired":false,"shares":1331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":7649,"derivative":{"exercise_price":0,"expiration_date":"2021-01-02","underlying":"Common Stock","underlying_shares":1331},"source":{"system":"sec-edgar","filing":"0001127602-19-001282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219001282/form4.xml","form_type":"4"}},{"id":3706019,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-04T21:17:58.000Z","date":"2019-01-02","kind":"tax_withholding","acquired":false,"shares":414,"price":304.69,"value":126141.66,"ownership":{"direct":true},"balance_after":917,"source":{"system":"sec-edgar","filing":"0001127602-19-001282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219001282/form4.xml","form_type":"4"}},{"id":3706018,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-04T21:17:58.000Z","date":"2019-01-02","kind":"exercise","acquired":true,"shares":1331,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1331,"source":{"system":"sec-edgar","filing":"0001127602-19-001282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219001282/form4.xml","form_type":"4"}},{"id":3871689,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-06T22:32:27.000Z","date":"2018-07-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018."}],"balance_after":12000,"derivative":{"exercise_price":0.9548,"expiration_date":"2028-07-04","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-18-009533","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224108/000117911018009533/edgar.xml","form_type":"4"}},{"id":4108993,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Performance Stock Unit","published_at":"2018-01-04T21:32:14.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":5390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The number of performance stock units (\"PSUs\") reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.   The actual number of PSUs that will vest will be determined based upon achievement of three-year performance goals adopted by the Compensation and Management Development Committee of the Board of Directors (the \"Committee\") in the first quarter of 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All eligible PSUs will vest on the later of January 2, 2021 or the date of the Committee's determination of the degree to which the annual performance goals have been satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All eligible PSUs will vest on the later of January 2, 2021 or the date of the Committee's determination of the degree to which the annual performance goals have been satisfied."}],"balance_after":5390,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5390},"source":{"system":"sec-edgar","filing":"0001127602-18-001115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218001115/form4.xml","form_type":"4"}},{"id":4108992,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-01-04T21:32:14.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":8980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":8980,"derivative":{"exercise_price":0,"expiration_date":"2021-01-02","underlying":"Common Stock","underlying_shares":8980},"source":{"system":"sec-edgar","filing":"0001127602-18-001115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218001115/form4.xml","form_type":"4"}},{"id":4249952,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-27T12:49:24.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017."}],"balance_after":12000,"derivative":{"exercise_price":4.08,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001615219-17-000049","document":"wf-form4_150115975112524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224108/000161521917000049/wf-form4_150115975112524.xml","form_type":"4"}},{"id":4273371,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":35962,"kind":"person","name":"CAPELLO JEFFREY D","position":1,"cik":"0001224108","reported_name":"CAPELLO JEFFREY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-24T00:56:44.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017."}],"balance_after":12000,"derivative":{"exercise_price":1.46,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-17-009555","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224108/000117911017009555/edgar.xml","form_type":"4"}}]}